Literature DB >> 1555975

Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma.

A W Fyles1, A J Dembo, R S Bush, W Levin, L A Manchul, J F Pringle, G A Rawlings, J F Sturgeon, G M Thomas, J Simm.   

Abstract

Between 1971 and 1985, 598 patients with ovarian carcinoma were treated with abdomino-pelvic radiation therapy. Acute complications included nausea and vomiting in 364 patients (61%) which were severe in 36, and diarrhea in 407 patients (68%), severe in 35. Leukopenia (less than 2.0 x 10(9) cells/liter) and thrombocytopenia (less than 100 x 10(9) cells/liter) occurred in 64 patients (11%) each. Treatment interruptions occurred in 136 patients (23%), and 62 patients (10%) did not complete treatment. In both situations the most common cause was myelosuppression. Late complications included chronic diarrhea in 85 patients (14%), transient hepatic enzyme elevation in 224 (44%), and symptomatic basal pneumonitis in 23 (4%). Serious late bowel complications were infrequent: 25 patients (4.2%) developed bowel obstruction and 16 required operation. Multivariate analysis was unable to determine any significant prognostic factors for bowel obstruction; however, the moving-strip technique of radiation therapy was associated with a significantly greater risk of developing chronic diarrhea, pneumonitis, and hepatic enzyme elevation than was the open beam technique. We conclude that abdomino-pelvic radiation therapy as used in these patients is associated with modest acute complications and a low risk of serious late toxicity.

Entities:  

Mesh:

Year:  1992        PMID: 1555975     DOI: 10.1016/0360-3016(92)90778-g

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Fractionated Palliative Pelvic Radiotherapy as an Effective Modality in the Management of Recurrent/Refractory Epithelial Ovarian Cancers: An Institutional Experience.

Authors:  Anshuma Bansal; Bhavana Rai; Shikhar Kumar; Vanita Suri; Sushmita Ghoshal
Journal:  J Obstet Gynaecol India       Date:  2016-07-29

2.  Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : four-year outcomes.

Authors:  Nathalie Rochet; Katja Lindel; Sonja Katayama; Kai Schubert; Klaus Herfarth; Andreas Schneeweiss; Christoph Sohn; Wolfgang Harms; Juergen Debus
Journal:  Strahlenther Onkol       Date:  2015-03-19       Impact factor: 3.621

3.  Whole abdomen radiation therapy in ovarian cancers: a comparison between fixed beam and volumetric arc based intensity modulation.

Authors:  Umesh Mahantshetty; Swamidas Jamema; Reena Engineer; Deepak Deshpande; Rajiv Sarin; Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Shyamkishore Shrivastava; Luca Cozzi
Journal:  Radiat Oncol       Date:  2010-11-15       Impact factor: 3.481

Review 4.  [D-xylose test of resorption as a method to determine radiation side effects in the small intestine].

Authors:  S Köst; K Keinert; F H Glaser
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 3.621

5.  Whole abdominal radiotherapy in ovarian cancer.

Authors:  Alberto Biete; Izaskun Valduvieco; Angels Rovirosa; Blanca Farrús; Francesc Casas; Carlos Conill
Journal:  Rep Pract Oncol Radiother       Date:  2010-03-23

6.  Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study.

Authors:  Nathalie Rochet; Meinhard Kieser; Florian Sterzing; Sonja Krause; Katja Lindel; Wolfgang Harms; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

7.  Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.

Authors:  Dandan Wang; Yueju Yin; Qichao Zhou; Zirong Li; Xingmin Ma; Yong Yin; Baosheng Li; Tong Bai; Dapeng Li; Jian Zhu
Journal:  Med Phys       Date:  2021-12-10       Impact factor: 4.506

8.  Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes.

Authors:  Nathalie Rochet; Rachel S Kahn; Andrzej Niemierko; Thomas F Delaney; Anthony H Russell
Journal:  Radiat Oncol       Date:  2013-10-14       Impact factor: 3.481

9.  Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol.

Authors:  Nathalie Rochet; Alexandra D Jensen; Florian Sterzing; Marc W Munter; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Journal:  BMC Cancer       Date:  2007-12-19       Impact factor: 4.430

10.  Effect of alpha-lipoic acid on radiation-induced small intestine injury in mice.

Authors:  Bae Kwon Jeong; Jin Ho Song; Hojin Jeong; Hoon Sik Choi; Jung Hwa Jung; Jong Ryeal Hahm; Seung Hoon Woo; Myeong Hee Jung; Bong-Hoi Choi; Jin Hyun Kim; Ki Mun Kang
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.